CN101862359A - Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof - Google Patents
Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof Download PDFInfo
- Publication number
- CN101862359A CN101862359A CN 201010144888 CN201010144888A CN101862359A CN 101862359 A CN101862359 A CN 101862359A CN 201010144888 CN201010144888 CN 201010144888 CN 201010144888 A CN201010144888 A CN 201010144888A CN 101862359 A CN101862359 A CN 101862359A
- Authority
- CN
- China
- Prior art keywords
- ethanol
- general flavone
- reflux extract
- acute turpinia
- leaf general
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an acute turpinia leaf general flavone ethanol reflux extract, which is prepared from acute turpinia through ethanol percolation extraction. A percolation extraction method comprises the following steps: taking acute turpinia leaf coarse powder; adding 30 to 90 percent of ethanol as extracting agents; carrying out soaking for 12 to 72 hours; using the speed of 1 to 8 ml/kg/minute for percolation; collecting percolation liquid accounting for 4 to 15 times of the amount of medical materials; recovering the ethanol; using nonpolar macroporous absorbent resin for absorbing water solution; using the ethanol lower than 20 percent for elution to remove impurities; then, using 25 to 90 percent of ethanol for elution; collecting elution liquid; recovering the ethanol; and carrying out concentration and drying to obtain the acute turpinia leaf general flavone ethanol reflux extract. The general flavone content is higher than 50 percent, and the flavone type major chemical ingredients are one kind or several kinds of materials in nuezhenoside, rhoifolin, hyperin, meletin, cyanidenon, apiolin and glucoside or aglycon thereof. The extract can be used as a neuraminidase inhibitor to be used for preventing and treating flu, and can be made into pharmaceutically acceptable preparations.
Description
Technical field
The present invention relates to a kind of acute turpinia leaf general flavone ethanol reflux extract and its production and use.
Background technology
Influenza virus is serious day by day at present, and influenza virus and respiratory tract disease and the systemic disease that causes are closely related, China is one of influenza country occurred frequently, not only populous, and living habit also helps the relay of influenza virus, the number of times of falling ill for each person every year reaches 0.3～0.7 time not to be waited, and key population reaches 2～4 times.There is serious threat in influenza to the mankind, New Development kind influenza virus especially, and it not only causes other infected by microbes of Secondary cases, and can directly cause organ to destroy and the allergy causing death.But effectively do not treat the method and the treatment means of influenza virus and disease (influenza) thereof at present,, cure the symptoms, not the disease as carry out the inflammatory reaction treatment at clinical symptoms.The method of present modal prevention and treatment influenza virus is to use influenza virus vaccine inoculation, non-specific anti virus herb or Western medicine oseltamivir phosphate (oseltamivir phosphate capsule)-neuraminidase inhibitor.Yet influenza virus vaccine prophylactic immunization drawback is that the inoculation crowd is selective, is not that everybody can inoculate.In addition, the influenza virus vaccine protective rate is not high, and guard time is also lacked (3～6 months).Though most of non-specific anti virus herbs lay claim to antivirus action at present, be not at influenza virus, and antivirus action mechanism are unclear.At many kind treatment affection of exogenous wind-cold of our former studies, the Chinese prescription of the flu that doctor trained in Western medicine is thought does not have the effect of direct resisiting influenza virus.Briefly, the Chinese prescription of not every treatment flu all has the effect of clear and definite inhibition influenza virus.Western medicine " oseltamivir phosphate (oseltamivir phosphate capsule; (3R; 4R; 5S)-4-acetamide-5-amino-3 (1-third 2-ethoxyethyl acetate)-1-cyclohexene-1 carboxylic acid, ethyl ester phosphate) " be neuraminidase inhibitor, influenza virus is entered cell specific inhibitory effect is arranged, but not only cost an arm and a leg, and have that some patients take that the back vomiting occurs, feels sick, side reactions such as insomnia, headache, stomachache, diarrhoea, dizziness, fatigue, nasal obstruction, pharyngalgia and cough.Oseltamivir phosphate capsule is that the esterase that is positioned at liver and intestinal in vivo is converted into active metabolite and plays the neuraminidase effect that suppresses, and also will influence its drug effect if patient's liver and intestinal organ dysfunction are undesired.In addition, the renal insufficiency patient also wants careful usefulness.
Therefore, specific aim suppresses influenza virus and duplicates, suppresses influenza neuraminidase hydrolysis cell surface sialic acid, thereby cause influenza virus not combine and to enter in the cell, and the minimizing influenza virus will be the cause of disease that treatment influenza virus sexuality is emitted in intracellular generation with cell surface receptor.
Summary of the invention
The purpose of this invention is to provide a kind of acute turpinia leaf general flavone ethanol reflux extract, suppress influenza neuraminidase hydrolysis cell surface sialic acid, cause influenza virus not combine and to enter in the cell with cell surface receptor, duplicating thereby can effectively suppress influenza virus, more importantly is the side reaction drawback that overcomes medicine.
Another object of the present invention has provided a kind of preparation method of acute turpinia leaf general flavone ethanol reflux extract.
Another object of the present invention has provided the purposes of the medicine of acute turpinia leaf general flavone ethanol reflux extract preparation prevention and treatment influenza and complication disease thereof;
Another object of the present invention has provided the pharmaceutical composition that contains acute turpinia leaf general flavone ethanol reflux extract.
Acute turpinia leaf general flavone ethanol reflux extract of the present invention, by being extracted, the Turpinia pomifera(Roxb) D O. alcohol percolation obtains, the alcohol percolation extracting method is: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 30～90% ethanol as extractant, flood after 12～72 hours, carry out percolation with 1～8ml/kg/ minute speed, collect the percolate of 4～15 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, remove impurity with the ethanol elution below 20%, reuse 25～90% ethanol elutions are collected eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferably, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 40～80% ethanol as extractant, flood after 24～48 hours, carry out percolation, collect the percolate of 4～13 times of amounts of medical material with 1～7ml/kg/ minute speed, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 30～85% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferred, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 45～75% ethanol as extractant, flood after 24～36 hours, carry out percolation, collect the percolate of 4～11 times of amounts of medical material with 1～6m/kg/ minute speed, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 35～80% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferred, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 50～70% ethanol as extractant, flood after 36 hours, carry out percolation, collect the percolate of 4～10 times of amounts of medical material with 1～5ml/kg/ minute speed, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 40～80% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferably, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 55～70% ethanol as extractant, flood after 24 hours, carry out percolation, collect the percolate of 5～8 times of amounts of medical material with 2～5ml/kg/ minute speed, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 45～80% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferred, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 60～70% ethanol as extractant, flood after 12 hours, carry out percolation, collect the percolate of 4～6 times of amounts of medical material with 3～5ml/kg/ minute speed, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 50～75% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferred, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 65% ethanol as extractant, flood after 36 hours, carry out percolation, collect the percolate of 7～10 times of amounts of medical material with 4ml/ minute speed, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 50～70% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferred, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 70% ethanol as extractant, flood after 72 hours, carry out percolation, collect the percolate of 4 times of amounts of medical material with 4～5ml/kg/ minute speed, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 50% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferably, described acute turpinia leaf general flavone ethanol reflux extract, wherein general flavone content is more than 50%.
Preferably, the acute turpinia leaf general flavone ethanol reflux extract of stating wherein also comprises flavonoid chemical constituent and acceptable liposoluble ingredient medically thereof.
Preferably, described acute turpinia leaf general flavone ethanol reflux extract, wherein the flavonoid chemical constituent contains one or more in nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin, Quercetin, luteolin, apigenin and glycosides thereof or the aglycon.
Preferably, described acute turpinia leaf general flavone ethanol reflux extract, wherein contain nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin reach 4.5%, 1.2% respectively, more than 2.5%.
Preferably, described acute turpinia leaf general flavone ethanol reflux extract wherein contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin total amount and reaches more than 23%.
The purposes that the present invention also provides acute turpinia leaf general flavone ethanol reflux extract to be used to prepare prevention and to treat the medicine of influenza and complication disease thereof, be used to suppress influenza virus, suppress influenza virus FM1, suppress neuraminidase, its complication is meant renal failure or refers to splenic trauma or/and injury of lung.
The present invention also provides a kind of acute turpinia leaf general flavone ethanol reflux extract preparation, and said preparation is a main active with described acute turpinia leaf general flavone ethanol reflux extract.
Acute turpinia leaf general flavone ethanol reflux extract of the present invention can extract effective inhibition neuraminic acid enzyme component, acute turpinia leaf general flavone ethanol reflux extract is along with the using dosage size variation, it suppresses the active ability of neuraminidase, be also corresponding the changing of height of neuraminic acid enzyme inhibition rate, and one-tenth positive correlation, acute turpinia leaf general flavone ethanol reflux extract can be by suppressing influenza virus surface neuraminidase, and then the inhibition influenza virus enters the cell the inside, inhibition has entered the influenza virus of cell the inside and has duplicated, propagation, thereby reduced the infection of influenza virus pair cell, growth, and prevention and treatment influenza and complication thereof.
The specific embodiment
Acute turpinia leaf general flavone ethanol reflux extract of the present invention, it is to obtain by the Turpinia pomifera(Roxb) D O. alcohol percolation is extracted, the alcohol percolation extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 30～90% ethanol as extractant, flood after 12～72 hours, carry out percolation with 1～8ml/kg/ minute speed, collect the percolate of 4～15 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, remove impurity with the ethanol elution below 20%, reuse 25～90% ethanol elutions are collected eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
Preferably, described acute turpinia leaf general flavone ethanol reflux extract, wherein general flavone content is more than 50%.
Preferably, described acute turpinia leaf general flavone ethanol reflux extract, wherein also comprise flavonoid chemical constituent and acceptable liposoluble ingredient medically thereof, wherein the flavonoid chemical constituent contains one or more in nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin, Quercetin, luteolin, apigenin and glycosides thereof or the aglycon.Wherein contain nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin reach 4.5%, 1.2% respectively, more than 2.5%.
Preferred, wherein contain nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin total amount and reach more than 23%.
Embodiment 1
Preparation method: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 50% ethanol as extractant, flood after 24 hours, carry out percolation with 7ml/kg/ minute speed, collect the percolate of 11 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with 15% ethanol elution, 50% ethanol elution of 6 times of amounts of reuse column volume, collect eluent, reclaim ethanol, concentrate, dry, get acute turpinia leaf general flavone ethanol reflux extract, general flavone content 53.6% contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin and reaches 15%, 5%, 3% respectively.
Embodiment 2
Preparation method: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 60% ethanol as extractant, flood after 48 hours, carry out percolation with 6ml/kg/ minute speed, collect the percolate of 9 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with 18% ethanol elution, 55% ethanol elution of 5 times of amounts of reuse column volume, collect eluent, reclaim ethanol, concentrate, dry, get acute turpinia leaf general flavone ethanol reflux extract, general flavone content 57.3% contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin and reaches 13%, 6%, 5% respectively.
Embodiment 3
Preparation method: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 65% ethanol as extractant, flood after 40 hours, carry out percolation with 5ml/kg/ minute speed, collect the percolate of 8 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with 20% ethanol elution, 60% ethanol elution of 5 times of amounts of reuse column volume, collect eluent, reclaim ethanol, concentrate, dry, get acute turpinia leaf general flavone ethanol reflux extract, general flavone content 63.7% contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin and reaches 10%, 8%, 7% respectively.
Embodiment 4
Preparation method: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 70% ethanol as extractant, flood after 72 hours, carry out percolation with 4ml/kg/ minute speed, collect the percolate of 7 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with 20% ethanol elution, 50% ethanol elution of 5 times of amounts of reuse column volume, collect eluent, reclaim ethanol, concentrate, dry, get acute turpinia leaf general flavone ethanol reflux extract, general flavone content 82.5% contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin and reaches 7%, 3%, 7% respectively.
Embodiment 5
Preparation method: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 75% ethanol as extractant, flood after 36 hours, carry out percolation with 2ml/kg/ minute speed, collect the percolate of 6 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with 20% ethanol elution, 50% ethanol elution of 6 times of amounts of reuse column volume, collect eluent, reclaim ethanol, concentrate, dry, get acute turpinia leaf general flavone ethanol reflux extract, general flavone content 74.6% contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin and reaches 6%, 6%, 11% respectively.
Embodiment 6
Preparation method: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 80% ethanol as extractant, flood after 24 hours, carry out percolation with 3ml/kg/ minute speed, collect the percolate of 5 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with 20% ethanol elution, 40% ethanol elution of 5 times of amounts of reuse column volume, collect eluent, reclaim ethanol, concentrate, dry, get acute turpinia leaf general flavone ethanol reflux extract, general flavone content 65.8.6% contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin and reaches 16%, 7%, 4% respectively.
Embodiment 7
Preparation method: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 85% ethanol as extractant, flood after 72 hours, carry out percolation with 1ml/kg/ minute speed, collect the percolate of 10 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with 17% ethanol elution, 30% ethanol elution of 4 times of amounts of reuse column volume, collect eluent, reclaim ethanol, concentrate, dry, get acute turpinia leaf general flavone ethanol reflux extract, general flavone content 58.7% contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin and reaches 18%, 6%, 8% respectively.
Experimental data 1, extraction process optimization research
Leaf of Turpinia pomifera (Roxb) D O. mainly contains chemical compounds such as flavonoid, organic acid, flavone compound is preferable with the ethanol extraction effect, therefore, we with concentration of alcohol (A), collect four of amount of alcohol (B), percolation speed (C), dip time (D) as the investigation factor, each factor is established three levels, carry out orthogonal experiment design (table 1, table 2) by L9 (34) orthogonal table extraction process is optimized research, investigating index is the total flavones extraction ratio.
Table 1 factor level table
Get 27 parts of leaf of Turpinia pomifera (Roxb) D O. medical materials, every group average three parts, totally nine groups, by table 1L9 (3
4) the orthogonal test table design experiment.The results are shown in Table 2.
Table 2L9 (3
4) orthogonal test table
Variance analysis
Orthogonal experiments is carried out variance analysis, the results are shown in Table 3.
Table 3 is the variance analysis of index with the total flavones rate of transform
＊F
1-0.05(2，2)＝19.0
＊＊F
1-0.01(2，2)＝99.0
Conclusion: intuitive analysis as can be known, it is bigger to the extraction effect influence to collect amount of alcohol (B), dip time (A), percolation speed (C) and concentration of alcohol (D) are less to the extraction effect influence.Table 3 The results of analysis of variance has further been verified the intuitive analysis conclusion, and promptly factor B has appreciable impact to extraction effect.Analyze in conjunction with the K value, determine that extraction conditions is: get leaf of Turpinia pomifera (Roxb) D O., with 70% alcohol dipping after 72 hours, with 3～6ml/kg/ minute percolation, collect 10 times of amounts of medical material percolate, reclaim ethanol, be evaporated to thick paste or the dry acute turpinia leaf general flavone ethanol reflux extract that gets.
Experimental data 2, leaf of Turpinia pomifera (Roxb) D O. total flavones purification research
The leaf of Turpinia pomifera (Roxb) D O. medical material proposes a large amount of non-flavone compounds after with ethanol extraction, must be further purified processing to alcohol extract, to improve the content of flavonoids effective constituent, impurity mostly is inorganic salt, saccharide, pectin and protein-based, esters, pigment etc. in the extracting solution, and the active component in the leaf of Turpinia pomifera (Roxb) D O. is a flavone compound, therefore, we adopt macroporous adsorbent resin and carry out purification research.
1) applied sample amount is investigated
Get the leaf of Turpinia pomifera (Roxb) D O. medical material and extract in right amount, D-101 macroporous resin (500ml) on the extracting solution, preceding 500ml collects one bottle, and the every 150ml in back collects one bottle, carries out the flavone qualitative identification, the flavone positive reaction is arranged to the 2000ml beginning.(quality that is equivalent to crude drug is 50g) do not detect flavone as yet when applied sample amount was 2000ml, so the preliminary extracting solution of determining sample 100g medical material on every 1000ml macroporous resin, i.e. resin volume: the crude drug quality is 10: 1.
2) investigation of eluting concentration
Get Turpinia pomifera(Roxb) D O. herbal extract 100ml (being equivalent to raw medicinal herbs 100g), be splined on 1000ml D101 resin.Water, 15%, 25%, 35%, 45%, 55% ethanol elution carry out assay to 15%, 25%, 35%, 45%, 55% ethanol elution successively, and part eluent evaporate to dryness calculates the rate of extract, the results are shown in Table 4.
The investigation of table 4 eluting concentration
Annotate :-expression HPLC does not detect flavones ingredient.
30%～50%, and effective ingredient can not leak and washes flavonoid glycoside with the optium concentration of ethanol elution as can be seen from Table 4.15% ethanol and 45% ethanol elution part total flavones amount are all lower in addition, and the impurity that 15% ethanol is removed is more, therefore, 15% ethanol just can be as the eluting solvent of impurity, 30%～50% ethanol then can be used as the desorption agent of flavone, can improve the content of total flavonoid glycoside in effective site like this, reach the purpose of separation and purification.
3) investigation of elution volume
Get leaf of Turpinia pomifera (Roxb) D O. medical material 100g and extract, extracting solution is splined on the 1000ml resin after reclaiming ethanol, washing 4000ml, and 15% ethanol is washed 6000ml, and 50% ethanol is washed 6000ml.The results are shown in Table 5.
The investigation of table 5 elution volume
"-" expression does not detect flavones ingredient; "+" expression detects flavones ingredient.
The result uses as can be seen from qualitative examination, 15% ethanol elution has been removed a large amount of non-flavones ingredients, having a small amount of effective ingredient runs off, simultaneously after eluting 3500ml, eluent paler colour (eluting power that is impurity descends) is so 15% ethanol part elution volume is defined as 3500ml (being every 1ml resin 3.5ml 15% ethanol elution).When 5000ml, effective ingredient eluting is complete during 50% ethanol elution, so with 50% ethanol 4000ml eluting (be 1ml resin with 4.5ml 45% ethanol elution).
Experimental data 3: acute turpinia leaf general flavone ethanol reflux extract is to the active inhibitory action of neuraminidase
Get acute turpinia leaf general flavone ethanol reflux extract, add suitable quantity of water and make dissolving, use tiring of neuraminidase inhibitor identification kit mensuration acute turpinia leaf general flavone ethanol reflux extract inhibition neuraminidase (N1) and see Table 6.
(1). standard curve is prepared: a. every hole in 96 hole luciferase targets adds 70 μ l neuraminidases and detects buffer; B. every hole adds 0,1,2,5,7.5,10 μ l H5N1 neuraminidases more respectively; C. every hole adds 0～20 μ l Milli-Q water again.
(2). the preparation of sample detection: a. every hole in 96 hole luciferase targets adds 70 μ l neuraminidases and detects buffer; B. every hole adds 10 μ l H5N1 neuraminidases again; C. every hole adds 0～10 μ l acute turpinia leaf general flavone ethanol reflux extract sample again; D. every hole adds 0～10 μ l Milli-Q water again.
(3). detect step:
A. vibrate the about 1min of mixing;
B.37 ℃ hatch 2min inhibitor and H5N1 neuraminidase are fully interacted, the sample of doing standard curve is also hatched together;
C. every hole adds 10 μ l neuraminidase fluorogenic substrates;
D. vibrate the about 1min of mixing again;
E.37 carry out fluoremetry after ℃ hatching 20～30min.Excitation wavelength is 360nm, and emission wavelength is 440nm.
(4). calculate the inhibition percentage ratio of sample according to standard curve, and calculate the IC50 of acute turpinia leaf general flavone ethanol reflux extract after doing concentration curve for the H5N1 neuraminidase for the H5N1 neuraminidase.The suppression ratio IC50 that acute turpinia leaf general flavone ethanol reflux extract reaches neuraminidase is 3.72mg/ml.See Table 6.
Table 6. acute turpinia leaf general flavone ethanol reflux extract suppresses the activity of neuraminidase
Can be clear that according to above-mentioned experimental result:
(1). acute turpinia leaf general flavone ethanol reflux extract can extract effective inhibition neuraminic acid enzyme component;
(2). acute turpinia leaf general flavone ethanol reflux extract is along with the using dosage size variation, and it suppresses the active ability of neuraminidase, and promptly the height of neuraminic acid enzyme inhibition rate is also corresponding changes, and becomes positive correlation;
(3). by above-mentioned experiment as seen, acute turpinia leaf general flavone ethanol reflux extract can be by suppressing influenza virus surface neuraminidase, and then suppress that influenza virus enters the cell the inside, the influenza virus that suppresses to have entered the cell the inside duplicates, breeds, thereby reduced infection, the growth of influenza virus pair cell, and prevention and treatment influenza and complication thereof.
Medical science and study of pharmacy personnel can't not do the inhibition influenza infection, duplicate in advance, or under the prerequisite of the experiment of inhibition neuraminidase, learn that in advance acute turpinia leaf general flavone ethanol reflux extract has prevention and treats the good result that the influenza virus sexuality is emitted.
Experimental data 4: acute turpinia leaf general flavone ethanol reflux extract is to the influence of FM1 influenza virus
Get acute turpinia leaf general flavone ethanol reflux extract, use influenza virus A-prime Mus lung adapted strain (FM1) and (H1N1) identify that acute turpinia leaf general flavone ethanol reflux extract suppresses the ability of FM1 influenza virus virulence.(1) .FM1 adopts cell median infective dose (TCID50) micromethod to the toxicity test of Testis et Pentis Canis passage cell (MDCK).(2). acute turpinia leaf general flavone ethanol reflux extract adopts the DMEM of serum-free that acute turpinia leaf general flavone ethanol reflux extract is done to be inoculated in the mdck cell hole that forms monolayer behind the serial dilution to the toxicity test of mdck cell, every hole 100 μ l, each dilution factor repeats 4 holes, establishes the normal cell contrast simultaneously.Culture plate is put 37 ℃, 5%CO
2Cultivate in the incubator, observation of cell pathological changes every day (CPE) is observed 3d continuously, with " +～++ ++ " the record result, press the Reed-Muench method and calculate medicine median toxic concentration (TD50) and maximal non-toxic concentration (TD0).(3). acute turpinia leaf general flavone ethanol reflux extract suppresses the effect of FM1 influenza virus and measures: mdck cell 5 * 10
5/ ml, every hole 100 μ l, in 96 orifice plates, 37 ℃, the interior cultivation of 5%CO2 incubator are inhaled and remove culture fluid in the hole next day, add 100TCID50 influenza virus liquid, every hole 100 μ l, supernatant is removed in suction behind 37 ℃ of absorption 1h.Wash 2 times with phosphate buffer (PBS), TD0 with medicine is the 1st hole, and the DMEM liquid of reuse serum-free is made serial dilution to acute turpinia leaf general flavone ethanol reflux extract, adds respectively in the cell of above-mentioned infective virus, establish virus control and normal control group simultaneously, 37 ℃, 5%CO
2Cultivate in the incubator, observe the mdck cell characteristics of lesion that influenza virus produces every day, i.e. cell monolayer degeneration becomes circle etc., for three days on end, calculates 50% of medicine and suppresses pathological changes concentration (IC50) and therapeutic index (TI).The calculating of TI: TI=TD50/IC50, the TI value is big more, shows that the safety range of medicine is big more.With Kruskal-Walis and Mann-Whitney method of inspection comparative test group and the cytopathic difference of virus control group, drug dose and suppression ratio that virus infected cell is avoided cytopathy (CPE) takes place are carried out correlation analysis, judge whether amount validity response relation.
(1) the .FM1 influenza virus is calculated through the Reed-Muench method the virulence of mdck cell, and its TCID50 is 10
-4.81(2). the TD0 of acute turpinia leaf general flavone ethanol reflux extract mdck cell is respectively 1044.86mg ± 28.11mg/100ml.(3). after acute turpinia leaf general flavone ethanol reflux extract made serial dilution, the 100TCID50 influenza virus is carried out inhibition test, median effective dose IC50 and the TI value of calculating medicine are big or small, the results are shown in Table 7.
Table 7. acute turpinia leaf general flavone ethanol reflux extract is to the IC50 (mg/100ml) of FM1 influenza virus and TI (x ± s)
As shown in Table 7, the cytopathogenic effect of acute turpinia leaf general flavone ethanol reflux extract inhibition FM1 influenza virus all strengthens along with the increase of drug dose.Drug dose and medicine are shown that to the correlation analysis that the suppression ratio of CPE carries out the dosage of acute turpinia leaf general flavone ethanol reflux extract and medicine are to being tangible positive correlation between the CPE suppression ratio.
Experimental data 5: acute turpinia leaf general flavone ethanol reflux extract infects the inhibitory action of Embryo Gallus domesticus to influenza virus
Get acute turpinia leaf general flavone ethanol reflux extract, use influenza virus A-prime Mus lung adapted strain (FM1) and (H1N1) identify that acute turpinia leaf general flavone ethanol reflux extract suppresses the ability that the FM1 influenza virus is duplicated and suppresses in Embryo Gallus domesticus.(1). FM1 influenza virus liquid is inoculated in no-special pathogen chick embryo allantois intracavity in 10 day age, and every embryo 0.2ml is hatched 72h for 37 ℃, observes and calculate half Embryo Gallus domesticus infective dose (EID50).(2). acute turpinia leaf general flavone ethanol reflux extract adopts the toxic action of Embryo Gallus domesticus, with physiological saline solution acute turpinia leaf general flavone ethanol reflux extract is done to be inoculated in 10d no-special pathogen in age chick embryo allantois intracavity behind the serial dilution, every embryo 0.2ml, each concentration is inoculated 6 embryos, hatch for 37 ℃, observe Embryo Gallus domesticus growth promoter situation, can survive the Cmax of 96h as the TD of medicine with Embryo Gallus domesticus.(3). acute turpinia leaf general flavone ethanol reflux extract inhibitory action to influenza virus in Embryo Gallus domesticus adopts, 0.1ml influenza virus liquid and different dilution acute turpinia leaf general flavone ethanol reflux extracts mix, 37 ℃ of effect 2h, be inoculated in no-special pathogen chick embryo allantoic cavity in 10 day age, every winding kind 6 embryos are hatched 72h for 37 ℃.The virus attack amount is 50EID50, establishes virus control, physiological saline solution normal control simultaneously, calculates the median effective dose (ED50) of acute turpinia leaf general flavone ethanol reflux extract to viral inhibition.
(1) the .FM1 influenza virus is calculated through the Reed-Muench method the virulence of Embryo Gallus domesticus, and its EID50 is 10
-5.07
(2). after acute turpinia leaf general flavone ethanol reflux extract is inoculated in Embryo Gallus domesticus, its growth promoter and normal control group basically identical.The 96h Embryo Gallus domesticus is all survived.Embryo Gallus domesticus gives acute turpinia leaf general flavone ethanol reflux extract stock solution and does not see chicken embryo death, so can think that TD0 is 8.4g/100ml.(3). acute turpinia leaf general flavone ethanol reflux extract inhibitory action to influenza virus in Embryo Gallus domesticus sees Table 8.
Table 8. acute turpinia leaf general flavone ethanol reflux extract infects the inhibitory action of Embryo Gallus domesticus to influenza virus
Compare with the virus control group: * P＜0.05
As shown in Table 8, acute turpinia leaf general flavone ethanol reflux extract has significant inhibitory effect (P＜0.05) at 11.25～90.0mg/ml to influenza virus, and ED50 is 10.24mg ± 0.49mg/ml, and TI is 41.42 ± 7.72.
Experimental data 6: acute turpinia leaf general flavone ethanol reflux extract is to the influence of influenza virus infection FM1 strain in the mice body
Get acute turpinia leaf general flavone ethanol reflux extract, use influenza virus A-prime Mus lung adapted strain (FM1) and (H1N1) identify the dead protective effect of acute turpinia leaf general flavone ethanol reflux extract influenza virus infection FM1 strain in the mice body.(1). influenza virus FM1 strain virus is inoculated every group of 10 BALB/C mice respectively, male and female half and half after doing 10 times of doubling dilutions.After the slight anesthesia of ether, give and different dilution viruses respectively for every group, every mice collunarium is inoculated 20 μ l.Observe the dead mouse situation of 10d, calculating LD50 by the Reed-Muench method is 10
-1.36So determine that the used modeling concentration of experiment is 10LD50.(2). acute turpinia leaf general flavone ethanol reflux extract is to the dead protective effect of influenza virus infection FM1 strain in the mice body: normal control group, influenza virus FM1 strain virus matched group, acute turpinia leaf general flavone ethanol reflux extract 11.25mg/ml, 22.5mg/ml, 45.0mg/ml, 90.0mg/ml dosage group etc. are irritated stomach respectively, irritate gastric capacity and only are 0.4ml/.After 3 days, each group is only used 10LD50 influenza virus FM1 strain collunarium infecting mouse 20 μ l/ under the slight anesthesia of ether except that the normal control group.The normal control group gives the normal saline with volume simultaneously.4 groups of administration are continued administration, normal control group and influenza virus FM1 strain virus control group administered physiological saline 8 days, and dosage is the same.Day by day observe animal morbidity and record death toll, observe 14d altogether, calculate mortality rate (mortality rate=every group of death toll/every group of total mice * 100%), the results are shown in Table 9.(3). acute turpinia leaf general flavone ethanol reflux extract is to the exponential influence of influenza virus infection FM1 strain lung in the mice body: normal control group, influenza virus FM1 strain virus matched group, acute turpinia leaf general flavone ethanol reflux extract 11.25mg/ml, 22.5mg/ml, 45.0mg/ml, 90.0mg/ml dosage group etc. are irritated stomach respectively, irritate gastric capacity and only are 0.4ml/.After 3 days, each group is only used 1.0LD50 influenza virus FM1 strain collunarium infecting mouse 20 μ l/ under the slight anesthesia of ether except that the normal control group.The normal control group gives the normal saline with volume simultaneously.4 groups of administration are continued administration, normal control group and influenza virus FM1 strain virus control group administered physiological saline 8 days, and dosage is the same.Behind viral infection, put to death mice on the 8th day, weigh, get lung and claim lung heavy, calculate lung index (lung index=lung quality/body constitution amount * 100%); In addition, get spleen and claim spleen heavy, calculate spleen index (spleen index=spleen quality/body constitution amount * 100%), the results are shown in Table 9.
Table 9. acute turpinia leaf general flavone ethanol reflux extract is to the death protection result of influenza virus infection FM1 strain in the mice body
Annotate: ※ ※ P＜0.01VS influenza virus model group ※ P＜0.05VS influenza virus model group
Table 10. acute turpinia leaf general flavone ethanol reflux extract is to the spleen index and the exponential influence of lung of influenza virus infection FM1 strain in the mice body
Annotate: #P＜0.05VS normal control group is annotated: ##P＜0.01VS normal control group
※ ※ p＜0.001 VS influenza virus model group ※ p＜0.05VS influenza virus model group
(1). as shown in Table 9, acute turpinia leaf general flavone ethanol reflux extract has significant protective effect (p＜0.01-p＜0.05) at 45.0～90.0mg/ml to the influenza virus infecting mouse.
(2). as shown in Table 10, acute turpinia leaf general flavone ethanol reflux extract has significant effect (p＜0.01-p＜0.05) at 45.0mg/ml-90.0mg/ml to the lung index suppression ratio of influenza virus infecting mouse.
Experimental data 7: acute turpinia leaf general flavone ethanol reflux extract is to the influence of chronic renal failure
1) SD rat, 200～240g, Shanghai west pul-Bi Kai laboratory animal responsibility company limited, the animal quality certification number: SCXK (Shanghai) 2003-0002
2) reagent and medicine adenine, adenine (content＞98% is the import packing, Chinese Shanghai, lot number 20010520), the acute turpinia leaf general flavone ethanol reflux extract that embodiment 4 preparation methoies are obtained;
3) test method: male SD rat, about body weight 220g, earlier feed 10 days normal growths with normal diet after, be divided into normal control group, administration experimental group and modeling matched group at random by body weight, 12 every group.Administration experimental group and modeling matched group are irritated stomach with adenine and are made chronic renal failure (CRF) model, irritate stomach with adenine 320mg/ (kgd), only make the about 2ml/ of suspension with distilled water, totally 20 days; Administration after 20 days, the administration experimental group is irritated stomach with acute turpinia leaf general flavone ethanol reflux extract 0.36g/ (kgd), acute turpinia leaf general flavone ethanol reflux extract is made suspension solution (0.06g/ml) with distilled water, each about 2ml/ only, stomach is irritated in gradation, normal control group and modeling matched group are irritated stomach with equal-volume water, and administration was used etherization with rat after 35 days. and every index is observed in the blood sampling of Mus arteria caudalis.
4) result:
Table 11. acute turpinia leaf general flavone ethanol reflux extract is to the influence of CRF kidney of rats function
Annotate: through the T check, administration experimental group and modeling matched group be " * " expression P＜0.05 relatively, and " * * " represents P＜0.01
This experiment is looked sidelong at purine with gland and is irritated after stomach sets up rat CRF model, modeling control rats lethargy, body weight obviously reduces, serum Bun, Ser obviously raises, Hb obviously descends, Ret obviously raises, show the rat impaired renal function, after giving the acute turpinia leaf general flavone ethanol reflux extract treatment. rat spirit is obviously bestirred oneself, and body weight is recovered gradually, improves creatinine clearance rate, promote the discharge of metabolite, reduce serum BUN, SCr concentration, renal function and anemia are obviously improved, and show that acute turpinia leaf general flavone ethanol reflux extract has preventive and therapeutic effect to kidney of rats damage due to the adenine.
Can be clear that according to above-mentioned experimental result:
(1). acute turpinia leaf general flavone ethanol reflux extract can extract effectively preventing chronic renal failure composition;
(2). acute turpinia leaf general flavone ethanol reflux extract has the active effect of the neuraminidase of inhibition simultaneously, the effect that also has the control chronic renal failure, overcome oseltamivir phosphate capsule sternly to the clear ability of creatinine and renal failure crowd's side effect, otherwise also had prevention effect.
Claims (20)
1. acute turpinia leaf general flavone ethanol reflux extract, by being extracted, the Turpinia pomifera(Roxb) D O. alcohol percolation obtains, the alcohol percolation extracting method is: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 30～90% ethanol as extractant, flood after 12～72 hours, carry out percolation with 1～8ml/kg/ minute speed, collect the percolate of 4～15 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, remove impurity with the ethanol elution below 20%, reuse 25～90% ethanol elutions are collected eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
2. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 1, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 40～80% ethanol as extractant, flood after 24～48 hours, carry out percolation with 1～7ml/kg/ minute speed, collect the percolate of 4～13 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 30～85% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
3. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 2, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 45～75% ethanol as extractant, flood after 24～36 hours, carry out percolation with 1～6m/kg/ minute speed, collect the percolate of 4～11 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 35～80% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
4. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 3, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 50～70% ethanol as extractant, flood after 36 hours, carry out percolation with 1～5ml/kg/ minute speed, collect the percolate of 4～10 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 40～80% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
5. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 3, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 55～70% ethanol as extractant, flood after 24 hours, carry out percolation with 2～5ml/kg/ minute speed, collect the percolate of 5～8 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 45～80% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
6. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 3, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 60～70% ethanol as extractant, flood after 12 hours, carry out percolation with 3～5ml/kg/ minute speed, collect the percolate of 4～6 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 50～75% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
7. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 4, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 65% ethanol as extractant, flood after 36 hours, carry out percolation with 4ml/ minute speed, collect the percolate of 7～10 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 50～70% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
8. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 1, concrete extracting method is as follows: get the leaf of Turpinia pomifera (Roxb) D O. coarse powder, with 70% ethanol as extractant, flood after 72 hours, carry out percolation with 4～5ml/kg/ minute speed, collect the percolate of 4 times of amounts of medical material, reclaim ethanol, aqueous solution adsorbs with nonpolar macroporous adsorption resin, removes impurity with the ethanol elution below 20%, reuse 50% ethanol, collect eluent, reclaim ethanol, concentrate, drying gets acute turpinia leaf general flavone ethanol reflux extract.
9. as each described acute turpinia leaf general flavone ethanol reflux extract of claim 1～8, wherein general flavone content is more than 50%.
10. as each described acute turpinia leaf general flavone ethanol reflux extract of claim 1～8, wherein also comprise flavonoid chemical constituent and acceptable liposoluble ingredient medically thereof.
11. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 10, wherein the flavonoid chemical constituent contains one or more in nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin, Quercetin, luteolin, apigenin and glycosides thereof or the aglycon.
12. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 11, wherein contain nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin reach 4.5%, 1.2% respectively, more than 2.5%.
13. acute turpinia leaf general flavone ethanol reflux extract as claimed in claim 12 wherein contains nuezhenoside, Radix seu Folium Tosicodendri Delavayi glucoside, hyperin total amount and reaches more than 23%.
14. be used to prepare the purposes of preventing and treating the medicine of influenza and complication disease thereof as each described acute turpinia leaf general flavone ethanol reflux extract of claim 1～13.
15., it is characterized in that suppressing influenza virus as the purposes of claim 14.
16., it is characterized in that suppressing influenza virus FM1 as the purposes of claim 14.
17., it is characterized in that suppressing neuraminidase as the purposes of claim 14.
18. as the purposes of claim 14, its complication is meant renal failure.
19. as the purposes of claim 14, its complication is meant splenic trauma or/and injury of lung.
20. an acute turpinia leaf general flavone ethanol reflux extract preparation is characterized in that, said preparation is a main active with each described acute turpinia leaf general flavone ethanol reflux extract of claim 1～13.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010144888 CN101862359A (en) | 2010-04-13 | 2010-04-13 | Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010144888 CN101862359A (en) | 2010-04-13 | 2010-04-13 | Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof |
Related Child Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100686002A Division CN102579523A (en) | 2010-04-13 | 2010-04-13 | Acute turpinia leaf total flavone ethanol percolation extract as well as preparation method and application thereof |
| CN2012100685974A Division CN102579522A (en) | 2010-04-13 | 2010-04-13 | Acute turpinia leaf total flavone ethanol percolation extract as well as preparation method and application thereof |
| CN2012100685052A Division CN102579521A (en) | 2010-04-13 | 2010-04-13 | Acute turpinia leaf total flavone ethanol percolation extract as well as preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101862359A true CN101862359A (en) | 2010-10-20 |
Family
ID=42954418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010144888 Pending CN101862359A (en) | 2010-04-13 | 2010-04-13 | Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101862359A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526086A (en) * | 2010-08-16 | 2012-07-04 | 江西山香药业有限公司 | Method for extracting ligustroflavone and application of ligustroflavone to preparation of medicines |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1680355A (en) * | 2005-01-20 | 2005-10-12 | 安徽科创中药天然药物研究所有限责任公司 | Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis |
| CN101249118A (en) * | 2007-02-25 | 2008-08-27 | 胡军 | Chinese medicine extract and medicine use thereof |
-
2010
- 2010-04-13 CN CN 201010144888 patent/CN101862359A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1680355A (en) * | 2005-01-20 | 2005-10-12 | 安徽科创中药天然药物研究所有限责任公司 | Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis |
| CN101249118A (en) * | 2007-02-25 | 2008-08-27 | 胡军 | Chinese medicine extract and medicine use thereof |
Non-Patent Citations (1)
| Title |
|---|
| 《中国中药杂志》 20090630 章光文等 山香圆叶中黄酮类成分研究 1603-1604 10-20 第34卷, 第12期 2 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526086A (en) * | 2010-08-16 | 2012-07-04 | 江西山香药业有限公司 | Method for extracting ligustroflavone and application of ligustroflavone to preparation of medicines |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bailly et al. | Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? | |
| CN101862357B (en) | Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof | |
| CN101890038B (en) | Nuezhenoside-rhoifolin-hyperin composite and application in medicinal preparation thereof | |
| CN101129455B (en) | Sophora extractive and method of preparing the same and application of the same | |
| CN101669979B (en) | Artemisia scoparia extractive and production method and applications thereof | |
| CN101891785B (en) | Extraction method of hyperin and application thereof in medicament preparation | |
| CN101906122B (en) | Method for extracting rhoifolin and prepared medicament application thereof | |
| CN101317904B (en) | Uses of smoked plum extract in resisting virus, bacteria, mycoplasma or chlamydia of livestock and poultry | |
| CN102633850A (en) | Rhoifolin extraction method and usage of drug prepared by rhoifolin | |
| CN101884651B (en) | Water extract of turpinia formosana leaves and preparation method and application thereof | |
| CN102935098A (en) | Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof | |
| CN102920751A (en) | Turpinia arguta leaf total flavonoid ethanol reflux extract, preparation method and uses thereof | |
| CN101897715B (en) | Nuezhenoside and rhoifolin composition and use thereof in preparation of drugs | |
| CN101899078B (en) | Extraction method of glossy privet fruit glycoside and application of glossy privet fruit glycoside in preparation of medicament | |
| CN101862359A (en) | Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof | |
| CN102784178A (en) | Turpinia montana leaf general flavone ethanol reflux extractive, preparation method and application thereof | |
| CN101904859B (en) | Rhoifolin and hyperin composition and application of medicines prepared therefrom | |
| CN101879197B (en) | Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof | |
| CN111317752B (en) | Medicine for preventing or treating influenza virus infection and application | |
| CN101890037B (en) | Nuezhenoside and hyperin composition and application thereof for preparing medicine | |
| CN102579522A (en) | Acute turpinia leaf total flavone ethanol percolation extract as well as preparation method and application thereof | |
| CN102579521A (en) | Acute turpinia leaf total flavone ethanol percolation extract as well as preparation method and application thereof | |
| CN102579523A (en) | Acute turpinia leaf total flavone ethanol percolation extract as well as preparation method and application thereof | |
| CN101862358B (en) | Acute turpinia leaf ethanol percolation extract, and preparation method and application thereof | |
| CN102526086A (en) | Method for extracting ligustroflavone and application of ligustroflavone to preparation of medicines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20101020 |
|
| WD01 | Invention patent application deemed withdrawn after publication |